HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Necrotizing fasciitis of the head and neck.
Abstract: Necrotizing fasciitis of the head and neck is a rapidly progressing and life-threatening condition. The purpose of this study was to describe the patients with a focus on clinical presentation, microbiology, treatment, and prognosis. Seventeen patients (10...
Wound care: the role of advanced wound-healing technologies.
Abstract: Wound repair and regeneration is a highly complex combination of matrix destruction and reorganization. Although major hurdles remain, advances during the past generation have improved the clinician's armamentarium in the medical and surgical management of...
Clinical Trial – Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients
The investigators hypothesize that given prophylactically, intravenous ondansetron will
attenuate the drop in blood pressure and heart rate frequently seen after spinal anesthesia.
Eighty-six American Society of Anesthesiologists (ASA) physical status I or II in
preoperative patient assessment, parturients age of 18 to 45 years scheduled to undergo
elective caesarean section will be enrolled.
Patients will be randomized to 2 groups: the ondansetron group, receiving 8 mg intravenous
ondansetron diluted in 10 mL of saline; or the placebo group, who were administered 10 mL of
saline given 5 minutes prior to performing the spinal anesthetic. Investigational Pharmacy
will randomize and dispense study drug.
Baseline measurements of vital signs will be taken. Otherwise standard management will then
be used:
– Patients must be NPO for 8 hours
– Pulse oximetry, EKG monitoring, noninvasive blood pressure at a minimum of every 3
minutes, more frequently if decided by the provider.
– Standard lumbar puncture in a sitting position the L3-L4 or L4-L5
– Whitacre pencil-point, 25 gauge
– Injectate: 2 mL of 0.75% hyperbaric bupivacaine, 100 mcg preservative free morphine, 20
mcg fentanyl
– Immediately after completing the subarachnoid injection, patients will be laid supine
with left lateral uterine displacement
The sensory level of anesthesia will be assessed in the standard fashion every five minutes
using ice. The motor component will tested using the Bromage scale for spinal anesthesia (0,
no paralysis; 1, inability to lift the thigh [only knee/feet]; 2, inability to flex the knee
[only feet]; 3, inability to move any joint in the legs).


